Reports Q3 revenue $191.84M, consensus $185.07M.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMPH:
- AMPH Upcoming Earnings Report: What to Expect?
- Amphastar Expands BAQSIMI® Distribution in Asia
- Amphastar Pharmaceuticals: Strategic Shift and Growth Catalysts Justify Buy Rating with $36 Target
- Amphastar price target lowered to $31 from $32 at BofA
- Amphastar Signs $2.8M Research Agreement with Hanxin